Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry for v3.4.2 was added and the v3.4.1 entry removed in the history; no other visible changes to the page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedA new revision entry v3.4.1 was added to the history and the previous v3.4.0 entry was removed. This change affects only the revision log and does not alter trial data or core content.SummaryDifference0.1%

- Check28 days agoChange DetectedNew UI elements were added to display the glossary and color-coded diff highlights (green for additions and red for deletions) and the latest revision label (v3.4.0) is now shown; the previous revision label (v3.3.4) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check42 days agoChange DetectedThe Record History shows a new site revision: v3.3.4 replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the history. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded revision v3.3.2 and removed revision v3.2.0 from the Study Record History; this update reflects administrative version control rather than substantive changes to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.